Mayumi T, Nimura Y, Kamiya J, Kondo S, Nagino M, Kanai M, Miyachi M, Hamaguchi K, Hayakawa N
First Department of Surgery, Nagoya University School of Medicine, Japan.
Int J Pancreatol. 1997 Aug;22(1):15-21. doi: 10.1007/BF02803900.
Combined resection of the celiac artery with a distal pancreatectomy (DP) increases the resectability and improves the overall prognosis of patients with locally advanced ductal cancer of the body and tail of the pancreas.
Carcinoma of the body and tail of the pancreas is often unresectable because of invasion to adjacent organs. We evaluated a DP including an en bloc resection of the celiac artery ("extended"), for pancreatic cancer that had invaded the common hepatic and/or celiac arteries.
Six cases of an "extended" DP were compared with 19 cases of a "standard" DP for pancreatic ductal carcinoma in terms of clinical and pathologic findings, perioperative course, and long-term outcome. We also compared the survival rate of these two groups with a third group consisting of 22 patients with unresectable pancreatic ductal carcinoma.
The mean operative time, postoperative serum aspartate aminotransferase concentration, and length of hospital stay did not significantly differ between the "extended" and "standard" DP groups. The cumulative 1- and 3-yr accumulated survival rates for the "extended," "standard," and unresectable groups were 40.0, 33.3, and 5.4, and 20.0, 16.6, and 0%, respectively. Statistically significant differences (p < 0.01) existed between the "extended" and unresected groups.
联合腹腔干切除与胰体尾远端切除术(DP)可提高局部进展期胰体尾导管癌患者的可切除性,并改善其总体预后。
胰体尾癌常因侵犯相邻器官而无法切除。我们评估了一种包括整块切除腹腔干的DP(“扩大”术式),用于已侵犯肝总动脉和/或腹腔干动脉的胰腺癌。
将6例“扩大”DP与19例“标准”DP治疗胰腺导管癌的临床和病理结果、围手术期过程及长期结局进行比较。我们还将这两组的生存率与由22例无法切除的胰腺导管癌患者组成的第三组进行比较。
“扩大”和“标准”DP组之间的平均手术时间、术后血清天冬氨酸转氨酶浓度及住院时间无显著差异。“扩大”组、“标准”组和无法切除组的1年和3年累积生存率分别为40.0%、33.3%、5.4%和20.0%、16.6%、0%。“扩大”组与未切除组之间存在统计学显著差异(p<0.01)。